These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 17156337

  • 1. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
    Manns J, Rieder S, Escher S, Eilers B, Forssmann WG, Elsner J, Forssmann U.
    Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. n-Nonanoyl-CCL14 (NNY-CCL14), a novel inhibitor of allergic airway inflammation is a partial agonist of human CCR2.
    Gupta S, Erdmann G, Schulz-Maronde S, Escher SE, Richter R, Forssmann WG, Elsner J, Forssmann U.
    Allergy; 2008 Oct; 63(10):1317-23. PubMed ID: 18782110
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. n-Nonanoyl-CC chemokine ligand 14, a potent CC chemokine ligand 14 analogue that prevents the recruitment of eosinophils in allergic airway inflammation.
    Forssmann U, Hartung I, Bälder R, Fuchs B, Escher SE, Spodsberg N, Dulkys Y, Walden M, Heitland A, Braun A, Forssmann WG, Elsner J.
    J Immunol; 2004 Sep 01; 173(5):3456-66. PubMed ID: 15322211
    [Abstract] [Full Text] [Related]

  • 6. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
    Morokata T, Suzuki K, Masunaga Y, Taguchi K, Morihira K, Sato I, Fujii M, Takizawa S, Torii Y, Yamamoto N, Kaneko M, Yamada T, Takahashi K, Shimizu Y.
    J Pharmacol Exp Ther; 2006 Apr 01; 317(1):244-50. PubMed ID: 16339911
    [Abstract] [Full Text] [Related]

  • 7. The carboxyl terminus of the chemokine receptor CCR3 contains distinct domains which regulate chemotactic signaling and receptor down-regulation in a ligand-dependent manner.
    Sabroe I, Jorritsma A, Stubbs VE, Xanthou G, Jopling LA, Ponath PD, Williams TJ, Murphy PM, Pease JE.
    Eur J Immunol; 2005 Apr 01; 35(4):1301-10. PubMed ID: 15739168
    [Abstract] [Full Text] [Related]

  • 8. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3.
    Struyf S, Proost P, Schols D, De Clercq E, Opdenakker G, Lenaerts JP, Detheux M, Parmentier M, De Meester I, Scharpé S, Van Damme J.
    J Immunol; 1999 Apr 15; 162(8):4903-9. PubMed ID: 10202035
    [Abstract] [Full Text] [Related]

  • 9. Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines.
    Duchesnes CE, Murphy PM, Williams TJ, Pease JE.
    Mol Immunol; 2006 Mar 15; 43(8):1221-31. PubMed ID: 16102831
    [Abstract] [Full Text] [Related]

  • 10. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
    Xanthou G, Duchesnes CE, Williams TJ, Pease JE.
    Eur J Immunol; 2003 Aug 15; 33(8):2241-50. PubMed ID: 12884299
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.
    Heath H, Qin S, Rao P, Wu L, LaRosa G, Kassam N, Ponath PD, Mackay CR.
    J Clin Invest; 1997 Jan 15; 99(2):178-84. PubMed ID: 9005985
    [Abstract] [Full Text] [Related]

  • 13. Significance of N-terminal proteolysis of CCL14a to activity on the chemokine receptors CCR1 and CCR5 and the human cytomegalovirus-encoded chemokine receptor US28.
    Richter R, Casarosa P, Ständker L, Münch J, Springael JY, Nijmeijer S, Forssmann WG, Vischer HF, Vakili J, Detheux M, Parmentier M, Leurs R, Smit MJ.
    J Immunol; 2009 Jul 15; 183(2):1229-37. PubMed ID: 19553544
    [Abstract] [Full Text] [Related]

  • 14. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
    Elsner J, Escher SE, Forssmann U.
    Allergy; 2004 Dec 15; 59(12):1243-58. PubMed ID: 15507091
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
    Elliott MB, Tebbey PW, Pryharski KS, Scheuer CA, Laughlin TS, Hancock GE.
    J Med Virol; 2004 Jun 15; 73(2):300-8. PubMed ID: 15122808
    [Abstract] [Full Text] [Related]

  • 16. I-TAC/CXCL11 is a natural antagonist for CCR5.
    Petkovic V, Moghini C, Paoletti S, Uguccioni M, Gerber B.
    J Leukoc Biol; 2004 Sep 15; 76(3):701-8. PubMed ID: 15178708
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists.
    Batt DG, Houghton GC, Roderick J, Santella JB, Wacker DA, Welch PK, Orlovsky YI, Wadman EA, Trzaskos JM, Davies P, Decicco CP, Carter PH.
    Bioorg Med Chem Lett; 2005 Feb 01; 15(3):787-91. PubMed ID: 15664858
    [Abstract] [Full Text] [Related]

  • 19. A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.
    Suzuki K, Morokata T, Morihira K, Sato I, Takizawa S, Kaneko M, Takahashi K, Shimizu Y.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):224-32. PubMed ID: 17336292
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.